Yuxing Xia, MD/PhD
Affiliations: | 2016-2023 | Neuroscience | University of Florida College of Medicine |
2023- | Neurology | University of California, Los Angeles, Los Angeles, CA |
Google:
"Yuxing Xia"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Xia Y, Bell BM, Giasson BI. (2023) Tau Lysine Pseudomethylation Regulates Microtubule Binding and Enhances Prion-like Tau Aggregation. International Journal of Molecular Sciences. 24 |
Xia Y. (2022) Role of Ubiquilin-2 in Proteostasis and Tau Aggregation in Tauopathies. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 42: 6168-6170 |
Xia Y, Prokop S, Bell BM, et al. (2022) Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice. Communications Biology. 5: 446 |
Xia Y, Lloyd GM, Giasson BI. (2021) Targeted proteolytic products of τ and α-synuclein in neurodegeneration. Essays in Biochemistry. 65: 905-912 |
Lloyd GM, Dhillon JS, Gorion KM, et al. (2021) Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model. Molecular Neurodegeneration. 16: 63 |
Hass EW, Sorrentino ZA, Xia Y, et al. (2021) Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies. Acta Neuropathologica Communications. 9: 146 |
Xia Y, Bell BM, Giasson BI. (2021) Tau K321/K353 pseudoacetylation within KXGS motifs regulates tau-microtubule interactions and inhibits aggregation. Scientific Reports. 11: 17069 |
Xia Y, Prokop S, Giasson BI. (2021) "Don't Phos Over Tau": recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies. Molecular Neurodegeneration. 16: 37 |
Krumm ZA, Lloyd GM, Francis CP, et al. (2021) Precision therapeutic targets for COVID-19. Virology Journal. 18: 66 |
Xia Y, Nasif L, Giasson BI. (2021) Pathogenic MAPT mutations Q336H and Q336R have isoform-dependent differences in aggregation propensity and microtubule dysfunction. Journal of Neurochemistry |